Invention Grant
- Patent Title: N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors
-
Application No.: US14778052Application Date: 2014-03-19
-
Publication No.: US09957265B2Publication Date: 2018-05-01
- Inventor: Christopher Dinsmore , Peter Fuller , David Guerin , Christopher F. Thompson , Qinglin Pu , Mark E. Scott , Jason David Katz , Ravi Kurukulasuriya , Joshua T. Close , Danielle Falcone , Jason Brubaker , Hongbo Zeng , Yunfeng Bai , Jianmin Fu , Norman Kong , Yumei Liu , Zhixiang Zheng
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Patricia A. Shatynski; John C. Todaro
- International Application: PCT/CN2014/000298 WO 20140319
- International Announcement: WO2014/146492 WO 20140925
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00
Abstract:
Provided are compounds of Formula I, a JAK inhibitor, and use thereof for the treatment of JAK-mediated diseases by the application.
Public/Granted literature
- US20160272633A1 N-(2-CYANO HETEROCYCLYL) PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS Public/Granted day:2016-09-22
Information query
